Skip to main content
Loading Events

« All Events

  • This event has passed.

Immunotherapy and Cancer Research – The Biology of Cancer

November 13, 2020 @ 11:00 am - 12:30 pm


The Biology of Cancer:
Exploring the Role of Race, Class, and Socioeconomics
in the Underserved and the Underrepresented

Behind cardiovascular disease, Cancer is the 2nd leading cause of deaths in the United States. What causes Cancer? Why have we not cured Cancer yet? What are some of the myths that surround Cancer care? Why do people of color seem to develop and die from Cancer at rates much higher than the majority of the population?

If you are interested in learning the answers to one or more of these questions, you should consider attending an engaging and stimulating, semester-long webinar series taught by cancer biologists, physicians, public health experts, and other cancer specialists from NCCU, UNC-Chapel Hill, and NC A&T. Additionally, you will have the opportunity to potentially hear from cancer survivors. These hour long webinars will be held during the Fall 2020 semester on Fridays at 11am. Come out and join us!


Photo of Jonathan S. Serody, MD

Jonathan S. Serody, MD

Elizabeth Thomas Professor of Medicine, Microbiology and Immunology
Director, Immunotherapy Program
Co-leader, Immunology Program
Chief of Hematology
UNC Lineberger Comprehensive Cancer Center
UNC School of Medicine
UNC School of Medicine
University of North Carolina at Chapel Hill

Immunotherapy and Cancer Research


Lecture Description

Immunotherapy has revolutionized the treatment of patients with cancer. There are now several different approaches that either activate a person’s immune system to kill their tumor or infuse immune cells or proteins that directly kill tumor cells. This lecture will highlight these new approaches to treat patients with tumor emphasizing the ability to use these therapies for multiple different cancers even when those have spread outside of the tumor site. Finally, we will discuss the paucity of individuals of color in the approval trials for these therapies and current approaches to understand this reluctance and whether these therapies are as effective to treat cancer in that group of individuals.

Learning Objectives:

  • Understand the role of different aspects of the immune system in the anti-tumor immune response.
  • Enhance understanding of how current therapies that stimulate the immune system function in patients with cancer.
  • Discuss role access to trials has on participation in those studies for new biological agents.


 Register to Attend via Zoom Webinar Link


November 13, 2020
11:00 am - 12:30 pm


Contact Email/Phone